Harvey Bienenstock
Director/Board Member bij HAIVISION SYSTEMS INC.
Vermogen: - $ op 31-03-2024
Profiel
Harvey Bienenstock is an Independent Director at Haivision Systems, Inc. since 2019 and Vice President-Finance at Haemosan, Inc. since 1993.
He was Vice President at IBEX Technologies, Inc. from 1982 to 1993 and Controller at First Quebec Corp.
from 1978 to 1982.
He completed his undergraduate and MBA degrees from McGill University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
HAIVISION SYSTEMS, INC.
-.--% | 18-01-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Harvey Bienenstock
Bedrijven | Functie | Begin |
---|---|---|
HAIVISION SYSTEMS INC. | Director/Board Member | 01-04-2019 |
Haemosan, Inc.
Haemosan, Inc. Regional BanksFinance Haemosan, Inc. operates as a bank holding company. The company was founded on August 20, 1979 and is headquartered in Mount-Royal, Canada. | Corporate Officer/Principal | 01-01-1993 |
Eerdere bekende functies van Harvey Bienenstock
Bedrijven | Functie | Einde |
---|---|---|
IBEX TECHNOLOGIES | Corporate Officer/Principal | 01-01-1993 |
First Quebec Corp. | Comptroller/Controller/Auditor | 01-01-1982 |
Opleiding van Harvey Bienenstock
McGill University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
HAIVISION SYSTEMS INC. | Electronic Technology |
Bedrijven in privébezit | 3 |
---|---|
IBEX Technologies, Inc.
IBEX Technologies, Inc. Medical SpecialtiesHealth Technology IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enzymes from flavobacterium heparinum, collagen assays, collagen antibodies, and diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montréal, Canada. | Health Technology |
Haemosan, Inc.
Haemosan, Inc. Regional BanksFinance Haemosan, Inc. operates as a bank holding company. The company was founded on August 20, 1979 and is headquartered in Mount-Royal, Canada. | Finance |
First Quebec Corp. |